Manufacturers Explore Shared Audits in Quest to Control Global Supply Chain
This article was originally published in The Gold Sheet
Executive Summary
Sharing audits could be the key to controlling the global supply chain, Rx-360 consortium members agreed at their first meeting this month. With suppliers inundated by audit requests in the wake of last year's heparin incident, many have started charging customers for hosting audits, they said. Shared audits are seen as cheaper and better. Rx-360-led audits prove the most popular of three proposed audit-sharing systems. The others involved sharing subscription audits or individual drug makers' audits, the least popular option. Rx-360 also would scan for emerging adulteration risks. Tiers 2 and 3 suppliers should be monitored too, Beroe says. Pfizer upgrades three key aspects of its supplier management program. Parexel, Novartis note stepped-up FDA enforcement with a new focus on supply chain management. Advice given on how to audit - and how not to.